We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.
The Fund (Class Z) underperformed its benchmark, the MSCI World Value Index, for the quarter ended December 31, 2024. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback